Literature DB >> 23836221

BCAT1 defines gliomas by IDH status.

Jared R Mayers, Matthew G Vander Heiden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23836221     DOI: 10.1038/nm.3263

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

Review 1.  Malignant gliomas in adults.

Authors:  Patrick Y Wen; Santosh Kesari
Journal:  N Engl J Med       Date:  2008-07-31       Impact factor: 91.245

Review 2.  Investigations of branched-chain amino acids and their metabolites in animal models of cancer.

Authors:  Vickie E Baracos; Michelle L Mackenzie
Journal:  J Nutr       Date:  2006-01       Impact factor: 4.798

Review 3.  Glutamine addiction: a new therapeutic target in cancer.

Authors:  David R Wise; Craig B Thompson
Journal:  Trends Biochem Sci       Date:  2010-08       Impact factor: 13.807

4.  Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.

Authors:  Houtan Noushmehr; Daniel J Weisenberger; Kristin Diefes; Heidi S Phillips; Kanan Pujara; Benjamin P Berman; Fei Pan; Christopher E Pelloski; Erik P Sulman; Krishna P Bhat; Roel G W Verhaak; Katherine A Hoadley; D Neil Hayes; Charles M Perou; Heather K Schmidt; Li Ding; Richard K Wilson; David Van Den Berg; Hui Shen; Henrik Bengtsson; Pierre Neuvial; Leslie M Cope; Jonathan Buckley; James G Herman; Stephen B Baylin; Peter W Laird; Kenneth Aldape
Journal:  Cancer Cell       Date:  2010-04-15       Impact factor: 31.743

Review 5.  Branched-chain [corrected] amino acid metabolism: implications for establishing safe intakes.

Authors:  Susan M Hutson; Andrew J Sweatt; Kathryn F Lanoue
Journal:  J Nutr       Date:  2005-06       Impact factor: 4.798

6.  Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids.

Authors:  Jurre J Kamphorst; Justin R Cross; Jing Fan; Elisa de Stanchina; Robin Mathew; Eileen P White; Craig B Thompson; Joshua D Rabinowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-13       Impact factor: 11.205

7.  An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.

Authors:  Dan Rohle; Janeta Popovici-Muller; Nicolaos Palaskas; Sevin Turcan; Christian Grommes; Carl Campos; Jennifer Tsoi; Owen Clark; Barbara Oldrini; Evangelia Komisopoulou; Kaiko Kunii; Alicia Pedraza; Stefanie Schalm; Lee Silverman; Alexandra Miller; Fang Wang; Hua Yang; Yue Chen; Andrew Kernytsky; Marc K Rosenblum; Wei Liu; Scott A Biller; Shinsan M Su; Cameron W Brennan; Timothy A Chan; Thomas G Graeber; Katharine E Yen; Ingo K Mellinghoff
Journal:  Science       Date:  2013-04-04       Impact factor: 47.728

8.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

9.  IDH1 and IDH2 mutations in gliomas.

Authors:  Hai Yan; D Williams Parsons; Genglin Jin; Roger McLendon; B Ahmed Rasheed; Weishi Yuan; Ivan Kos; Ines Batinic-Haberle; Siân Jones; Gregory J Riggins; Henry Friedman; Allan Friedman; David Reardon; James Herndon; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein; Darell D Bigner
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 176.079

10.  Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells.

Authors:  Cosimo Commisso; Shawn M Davidson; Rengin G Soydaner-Azeloglu; Seth J Parker; Jurre J Kamphorst; Sean Hackett; Elda Grabocka; Michel Nofal; Jeffrey A Drebin; Craig B Thompson; Joshua D Rabinowitz; Christian M Metallo; Matthew G Vander Heiden; Dafna Bar-Sagi
Journal:  Nature       Date:  2013-05-12       Impact factor: 49.962

View more
  12 in total

Review 1.  MR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy.

Authors:  Chloé Najac; Sabrina M Ronen
Journal:  Top Magn Reson Imaging       Date:  2016-10

2.  The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cells.

Authors:  Yinxing Liu; Misty R Gilbert; Natasha Kyprianou; Vivek M Rangnekar; Craig Horbinski
Journal:  Acta Neuropathol       Date:  2014-08-19       Impact factor: 17.088

Review 3.  Branched-Chain Amino Acids and Seizures: A Systematic Review of the Literature.

Authors:  Shaun E Gruenbaum; Eric C Chen; Mani Ratnesh Singh Sandhu; Ketaki Deshpande; Roni Dhaher; Denise Hersey; Tore Eid
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

4.  11C-Methionine positron emission tomography delineates non-contrast enhancing tumor regions at high risk for recurrence in pediatric high-grade glioma.

Authors:  John T Lucas; Nick Serrano; Hyun Kim; Xingyu Li; Scott E Snyder; Scott Hwang; Yimei Li; Chia-Ho Hua; Alberto Broniscer; Thomas E Merchant; Barry L Shulkin
Journal:  J Neurooncol       Date:  2017-01-11       Impact factor: 4.130

5.  Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative glioma.

Authors:  Li Chen; Zoya Voronovich; Kenneth Clark; Isaac Hands; Jonathan Mannas; Meggen Walsh; Marina N Nikiforova; Eric B Durbin; Heidi Weiss; Craig Horbinski
Journal:  Neuro Oncol       Date:  2014-05-23       Impact factor: 13.029

6.  BCAT1 is a New MR Imaging-related Biomarker for Prognosis Prediction in IDH1-wildtype Glioblastoma Patients.

Authors:  Hye Rim Cho; Hyejin Jeon; Chul-Kee Park; Sung-Hye Park; Koung Mi Kang; Seung Hong Choi
Journal:  Sci Rep       Date:  2017-12-18       Impact factor: 4.379

Review 7.  Glioma: experimental models and reality.

Authors:  Krissie Lenting; Roel Verhaak; Mark Ter Laan; Pieter Wesseling; William Leenders
Journal:  Acta Neuropathol       Date:  2017-01-10       Impact factor: 17.088

8.  Assessment of bevacizumab resistance increased by expression of BCAT1 in IDH1 wild-type glioblastoma: application of DSC perfusion MR imaging.

Authors:  Hye Rim Cho; Bora Hong; Hyeonjin Kim; Chul-Kee Park; Sung-Hye Park; Sunghyouk Park; Seung Hong Choi
Journal:  Oncotarget       Date:  2016-10-25

9.  MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma.

Authors:  Abigail R Molloy; Chloé Najac; Pavithra Viswanath; Aliya Lakhani; Elavarasan Subramani; Georgios Batsios; Marina Radoul; Anne Marie Gillespie; Russell O Pieper; Sabrina M Ronen
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

Review 10.  Isocitrate dehydrogenase variants in cancer - Cellular consequences and therapeutic opportunities.

Authors:  Shuang Liu; Tom Cadoux-Hudson; Christopher J Schofield
Journal:  Curr Opin Chem Biol       Date:  2020-08-08       Impact factor: 8.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.